Contact information: Jessica Wise, 503-244-7404, ext. 22, [email protected] or
Tara Rolstad, 503-244-7404, ext. 19, [email protected] or
Jennifer Somers, Ruder Finn, PH 212-715-1654, [email protected]

DIAGNOSTIC SURVEY HELPS GUIDE PEOPLE WITH SCALP CONDITIONS TOWARD PROPER TREATMENT

"Scalp Sense" educates those frustrated by scalp problems

PORTLAND, OR - Millions of Americans suffering from scalp dermatoses-a group of chronic, recurring conditions characterized by an irritated, itchy scalp-can now get guidance in treating these often frustrating and painful conditions by completing a survey developed by a Stanford University medical researcher.

Called "Scalp Sense," the survey is the first of its kind to use a detailed questionnaire and scientific methods to help respondents identify their scalp condition and direct them to appropriate treatment.

According to the National Psoriasis Foundation (NPF), the questionnaire was developed in order to provide an easy and non-threatening way for people to identify their problematic scalp conditions and then direct them toward an appropriate treatment.

"Many people with scalp problems do not see a physician or, frustrated by previously limited options, have not seen one for a long time," said Gail Zimmerman, President and CEO of the NPF. "They need to know that they can get help. A tool like 'Scalp Sense' can help identify the nature of their problem, while guiding them toward an effective solution."

There are various types of scalp dermatoses, some of which can be quite severe and painful or flare up unpredictably. The most common is psoriasis of the scalp, which affects more than 3.5 million people. Psoriasis is characterized by raised, inflamed lesions covered with silver-white, flaky scales, and can affect skin anywhere on the body in addition to the scalp. Other common types of scalp dermatoses include seborrheic dermatitis and eczema.

Common symptoms of seborrheic dermatitis include scaling and flaking, as well as itching and crusting. Eczema -- sometimes referred to as atopic dermatitis -- is usually first characterized by uncontrollable itching, which then leads to red, irritated and flaky skin when the affected areas are scratched.

"Scalp Sense" differs from other diagnostic surveys because it uses formalized algorithms to take into account patient preferences as they relate to their scalp condition. The survey takes a logical, scientific approach to calculate the results while, in appropriate circumstances, encouraging patients to seek help from a dermatologist.

The "Scalp Sense" questionnaire consists of 40 multiple-choice questions that evaluate the type and severity of symptoms and assess the steps taken to treat them. After submitting their responses for evaluation, respondents receive a detailed, personalized analysis of their condition and, when appropriate, a recommendation to see a dermatologist. The evaluation includes four categories: possible diagnosis, clinical severity, therapeutic options, and education.

"Scalp Sense" was developed on the basis of focus group sessions with patients, dermatologists and psoriasis clinic nurses. The sessions were used to identify the symptoms that most bother patients suffering from scalp dermatoses, the factors that motivate them to seek therapy, and the treatment efforts they commonly undertake, for incorporation into the survey. Dr. Suephy Chen, dermatology clinician, Stanford University School of Medicine, developed the questionnaire.

To obtain the free "Scalp Sense" questionnaire, call toll-free, 1-877-DRY-SCALP (877-379-7225) or visit the "Scalp Sense" web site at http://www.scalpsense.org. When you visit our web site, you can get immediate results from your questionnaire as well as additional information on scalp dermatoses.

For more information about all forms of psoriasis and its treatments, including scalp psoriasis, call the National Psoriasis Foundation at (800) 723-9166 or visit the NPF web site at http://www.psoriasis.org.

For more information on eczema/atopic dermatitis, call the National Eczema Association for Science and Education (NEASE) at (800) 818-7546 or visit the NEASE web site at http://www.eczema-assn.org.

The NPF is a lay nonprofit organization committed to improving the lives of people who have psoriasis and psoriatic arthritis through education and advocacy, and supporting research to find the cure.

For additional information on "Scalp Sense," contact Jennifer Somers at Ruder Finn at (212) 715-1654 or e-mail [email protected].

# # #

"Scalp Sense(tm)" is made possible by an unrestricted educational grant from the Connetics Corporation, makers of Luxiq(tm) (betamethasone valerate) Foam, 0.12%, a prescription medication indicated for the treatment of steroid-responsive scalp dermatoses.

MEDIA CONTACT
Register for reporter access to contact details